Monogram Technologies Inc
MGRM5.490USD
+0.100+1.86%
Horarios del mercado （ET）Cotizaciones retrasadas 15 min
194.05MCap. mercado
PérdidaP/E TTM
Más Datos de Monogram Technologies Inc Compañía
Monogram Technologies Inc., formerly Monogram Orthopaedics Inc., is an artificial intelligence (AI)-driven robotics company focused on improving human health, with an initial focus on orthopedic surgery. The Company is developing a product solution architecture to enable patient-optimized orthopedic implants at scale by combining three-dimensional (3D) printing, advanced machine vision, AI and robotics. Its mBos precision robotic surgical system is designed to autonomously execute optimized paths for high-precision insertion of its mPress press-fit implants. The Company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation necessary for reconstructive joint replacement procedures. The Company is also exploring other clinical and commercial applications for the mBos with mVision navigation.
Información de la empresa
Símbolo de cotizaciónMGRM
Nombre de la empresaMonogram Technologies Inc
Fecha de salida a bolsaMay 18, 2023
Director ejecutivoMr. Benjamin Sexson
Número de empleados27
Tipo de seguridadOrdinary Share
Fin del año fiscalMay 18
Dirección53 Bridge Street Unit 507
CiudadBROOKLYN
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal11201
Teléfono17185763205
Sitio Webhttps://www.monogramtechnologies.com/
Símbolo de cotizaciónMGRM
Fecha de salida a bolsaMay 18, 2023
Director ejecutivoMr. Benjamin Sexson
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Benjamin Sexson
Mr. Benjamin Sexson
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
4.01M
--
Mr. Douglas Unis, M.D.
Mr. Douglas Unis, M.D.
Director and founder
Director and founder
3.48M
-1.62%
Mr. Noel Knape, CPA
Mr. Noel Knape, CPA
Chief Financial Officer
Chief Financial Officer
288.79K
+0.11%
Mr. Kamran Shamaei, Ph.D.
Mr. Kamran Shamaei, Ph.D.
Chief Technology Officer
Chief Technology Officer
2.93K
--
Mr. Richard L. (Rick) Van Kirk, Jr.
Mr. Richard L. (Rick) Van Kirk, Jr.
Independent Director
Independent Director
--
--
Mr. Chris Tyson
Mr. Chris Tyson
Executive Vice President
Executive Vice President
--
--
Ms. Colleen M. Gray
Ms. Colleen M. Gray
Independent Director
Independent Director
--
--
Mr. Paul Riss, CPA
Mr. Paul Riss, CPA
Independent Director
Independent Director
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Benjamin Sexson
Mr. Benjamin Sexson
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
4.01M
--
Mr. Douglas Unis, M.D.
Mr. Douglas Unis, M.D.
Director and founder
Director and founder
3.48M
-1.62%
Mr. Noel Knape, CPA
Mr. Noel Knape, CPA
Chief Financial Officer
Chief Financial Officer
288.79K
+0.11%
Mr. Kamran Shamaei, Ph.D.
Mr. Kamran Shamaei, Ph.D.
Chief Technology Officer
Chief Technology Officer
2.93K
--
Mr. Richard L. (Rick) Van Kirk, Jr.
Mr. Richard L. (Rick) Van Kirk, Jr.
Independent Director
Independent Director
--
--
Mr. Chris Tyson
Mr. Chris Tyson
Executive Vice President
Executive Vice President
--
--
Desglose de ingresos
FY2024
Sin datos
Por regiónUSD
Nombre
Ganancia
Proporción
United States
0.00
0.00%
Por negocio
Por región
Sin datos
Estadísticas de accionistas
Actualizado: jue., 17 de jul
Actualizado: jue., 17 de jul
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Zimmer Biomet Holdings, Inc.
26.98%
Sexson (Benjamin)
11.08%
Unis (Douglas)
9.61%
Icahn School of Medicine at Mount Sinai
6.53%
Pro-Dex Inc
5.06%
Other
40.75%
Accionistas
Accionistas
Proporción
Zimmer Biomet Holdings, Inc.
26.98%
Sexson (Benjamin)
11.08%
Unis (Douglas)
9.61%
Icahn School of Medicine at Mount Sinai
6.53%
Pro-Dex Inc
5.06%
Other
40.75%
Tipos de accionistas
Accionistas
Proporción
Holding Company
26.98%
Individual Investor
21.50%
Corporation
11.58%
Investment Advisor
3.84%
Investment Advisor/Hedge Fund
1.04%
Research Firm
0.16%
Hedge Fund
0.05%
Other
34.86%
Participación institucional
Actualizado: mar., 1 de jul
Actualizado: mar., 1 de jul
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q2
72
13.80M
38.16%
+158.05K
2025Q1
70
13.80M
38.67%
+170.39K
2024Q4
67
13.51M
39.38%
+322.57K
2024Q3
55
13.06M
41.28%
+264.50K
2024Q2
44
12.27M
38.78%
-449.19K
2024Q1
41
12.14M
38.38%
-162.63K
2023Q4
32
12.30M
41.64%
+1.57M
2023Q3
22
10.73M
36.66%
+319.53K
2023Q2
15
7.55M
25.82%
+7.55M
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Sexson (Benjamin)
4.01M
11.23%
--
--
Mar 05, 2025
Unis (Douglas)
3.48M
9.74%
-57.12K
-1.62%
Mar 05, 2025
Icahn School of Medicine at Mount Sinai
2.36M
6.61%
--
--
Mar 05, 2025
Pro-Dex Inc
1.83M
5.12%
--
--
Mar 05, 2025
The Vanguard Group, Inc.
896.70K
2.51%
+241.15K
+36.79%
Mar 31, 2025
Knape (Noel)
288.79K
0.81%
+329.00
+0.11%
Mar 05, 2025
Geode Capital Management, L.L.C.
243.41K
0.68%
+17.03K
+7.52%
Mar 31, 2025
Buckingham Strategic Partners, LLC
213.68K
0.6%
+12.33K
+6.12%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
93.73K
0.26%
-846.00
-0.89%
Mar 31, 2025
Ver más
ETFs relacionados
Actualizado: sáb., 2 de ago
Actualizado: sáb., 2 de ago
Nombre
Proporción
iShares Micro-Cap ETF
0.02%
iShares Micro-Cap ETF
Proporción0.02%
Dividendos
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
